Mazabraud Yann bought RYTM
August 12, 2026 · Form 4 insider transaction
Mazabraud Yann bought 46,625 shares of Rhythm Pharmaceuticals, Inc. at $6.80 per share, a transaction worth $317.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
46,625
Price
$6.80
Total value
$317.1K
InsiderMazabraud Yann
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 12, 2026
Filing dateAugust 14, 2026
Shares owned after112,655
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2026.